Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Survey Results Add To DXM Abuse Concerns; CHPA Touts Education

This article was originally published in The Tan Sheet

Executive Summary

Results from a national survey of illicit drug use by students provide a platform to address the problem of young people abusing over-the-counter cough and cold medicines containing dextromethorphan, the Consumer Healthcare Products Association said Dec. 21
Advertisement

Related Content

“Snurf” Abuse Reports Revive Interest In DXM Bills
Dextromethorphan Under Scrutiny For Possible International Regulation
“Troubling” DXM Abuse Numbers Underscore Need For Education – CHPA
Students’ OTC Cough/Cold Drug Abuse Steady, Monitoring Survey Says
House DXM Bill Sponsor Expects Senate To Approve Measure This Year
More OTC-related cases in ERs
CHPA Offers Retailers Toolkit To Slow DXM Abuse
Dextromethorphan Abuse Study Raises Questions On Prevention Strategies
Dextromethorphan Abuse Study Raises Questions On Prevention Strategies
Dextromethorphan Bulk-Sale Limit Clears House, But Stalls In Senate

Topics

Advertisement
UsernamePublicRestriction

Register

PS100074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel